New blood test could catch liver cancer earlier
NCT ID NCT07298577
Summary
This study aims to see if a new blood test score, called GAAD, can help doctors find liver cancer earlier when used alongside standard ultrasound scans. It will enroll 2,100 high-risk patients with chronic liver disease or cirrhosis across Asia Pacific. Participants will get the GAAD blood test and an ultrasound every six months for two years to compare how well this combination works versus current methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C, CHRONIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Medicine Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand
Conditions
Explore the condition pages connected to this study.